SCHEMBL19169552

SCHEMBL19169552

Cc1ccc(CC(=O)C(C)(C)C)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.47
PRMT6 Q96LA8 1/20 0.42
DAO P14920 1/20 0.39
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KMT2A Q03164 3/20 0.37
THRB P10828 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4C Q9H3R0 1/20 0.36
TP53 P04637 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260565 0.78 KMT2A (0.50) RIPK1PRMT6DAOL3MBTL1KMT2A
SCHEMBL9374537 0.78 PRMT6 (0.47) RIPK1PRMT6DAONPC1RAB9A
SCHEMBL6844117 0.73 PRMT6 (0.50) RIPK1PRMT6DAONPC1RAB9A
SCHEMBL16563690 0.72 SMN1; SMN2 (0.53) RIPK1PRMT6SMN1; SMN2L3MBTL1KMT2A
SCHEMBL1848012 0.70 BLM (0.50) RIPK1PRMT6DAONPC1RAB9A
SCHEMBL8964660 0.69 PRMT6 (0.47) RIPK1PRMT6DAONPC1RAB9A
SCHEMBL23032229 0.69 RIPK1 (0.58) RIPK1PRMT6NPC1RAB9ATHRB
SCHEMBL6870551 0.69 HPGD (0.51) RIPK1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4661907 0.69 POLB (0.46) RIPK1PRMT6DAONPC1RAB9A
SCHEMBL9917335 0.69 PRMT6 (0.50) RIPK1PRMT6NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170210734-A1 Substituted Azaspiro(4.5)Decane Derivatives GRUENENTHAL GMBH (DE) 2017-07-27 US disclosed
US-20170210734-A1 Substituted Azaspiro(4.5)Decane Derivatives GRUENENTHAL GMBH (DE) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210734-A1 Substituted Azaspiro(4.5)Decane Derivatives OPRL1, OPRM1, OPRD1 RIPK1 1956/4885PRMT6 2212/4885DAO 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.